Skip to Content

DaVita Inc DVA

Morningstar Rating
$122.87 +1.98 (1.64%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

Price vs Fair Value

DVA is trading at a 1% premium.
Price
$122.87
Fair Value
$982.00
Uncertainty
High
1-Star Price
$375.10
5-Star Price
$71.70
Economic Moat
Wrygp
Capital Allocation
Vtlmwnt

Bulls Say, Bears Say

Bulls

Excluding recent COVID-19 mortality challenges and obesity drug expansion, the ESRD patient population may grow at a healthy rate in the U.S. and around the globe for the long run, which should benefit DaVita.

Bears

Potential U.S. healthcare policy changes could reduce industry profitability if insurance coverage shifts away from employer-based plans and if Medicare reimbursement rates aren't changed significantly.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if DVA is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$120.89
Day Range
$120.78123.31
52-Week Range
$71.51128.28
Bid/Ask
$86.80 / $144.44
Market Cap
$10.73 Bil
Volume/Avg
793,849 / 941,956

Key Statistics

Price/Earnings (Normalized)
14.73
Price/Sales
0.95
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield
2.99%

Company Profile

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Sector
Healthcare
Industry
Medical Care Facilities
Stock Style Box
Mid Core
Total Number of Employees
70,000

Competitors

Valuation

Metric
DVA
THC
HCA
Price/Earnings (Normalized)
14.7314.0517.19
Price/Book Value
10.385.55
Price/Sales
0.950.451.30
Price/Cash Flow
6.174.008.54
Price/Earnings
DVA
THC
HCA

Financial Strength

Metric
DVA
THC
HCA
Quick Ratio
1.061.100.86
Current Ratio
1.191.511.18
Interest Coverage
3.952.794.98
Quick Ratio
DVA
THC
HCA

Profitability

Metric
DVA
THC
HCA
Return on Assets (Normalized)
6.40%5.45%9.75%
Return on Equity (Normalized)
112.35%110.21%
Return on Invested Capital (Normalized)
10.05%11.10%16.43%
Return on Assets
DVA
THC
HCA
See how this stock stacks up to its competitors with Morningstar Investor

Medical Care Facilities Industry Comparables

Sponsor Center